Effect of dietary protein and enalapril on proximal tubular delivery and absorption of albumin in nephrotic rats.
In passive Heymann nephritis (PHN), angiotensin-converting enzyme inhibition (ACEI) or a low dietary protein intake decreases albuminuria (UAlbV). Although this reduction in albuminuria appears to result from an improvement in glomerular permselectivity, the effect of these treatments on albumin permeation and absorption by the nephron has not been clarified. This study used micropuncture techniques to examine the effect of these two treatments on albumin permeation (by measuring the delivery of albumin to the proximal tubule) and the tubular absorption of albumin. PHN rats (12-18 days after injection of FX1A) were switched from 23% to either 40% protein diet (HP), 40% protein diet and concomitantly treated with enalapril (40 mg.kg-1.day-1) (HPE), or to 8% (LP) protein diet for 4-6 days. Although left kidney glomerular filtration rate (GFR) did not differ among the groups, UAlbV from the left kidney in LP and HPE was only 20-40% of that observed for the HP group. In protocol 1, the fractional recovery of albumin (FRAlb) in urine was calculated following injection of artificial tubular fluid containing [14C]inulin and 125I-labeled albumin into the earliest identifiable proximal loops. There were no differences in FRAlb among the three groups. In protocol 2, timed quantitative collections of tubular fluid were obtained from proximal tubular loops. The rate of albumin delivery to the earliest accessible loops of the proximal tubule was significantly lower for the LP and HPE groups compared with the HP group. For each group, albumin concentration corrected for water absorption was not altered along the proximal tubule. The data indicate that alterations of dietary protein intake or ACEI treatment results in large changes in the delivery of albumin at the proximal tubule that could singularly account for the changes in urinary albumin excretion.
Fitzgibbon
W R
WR
Department of Medicine, Medical University of South Carolina, Charleston 29425, USA.
Webster
S K
SK
Imamura
A
A
Ploth
D W
DW
Hutchison
F N
FN
D000042:Absorption / Q000187:drug effects; D000418:Albumins / Q000378:metabolism*; D000419:Albuminuria / Q000378:metabolism; D000818:Animals; D004044:Dietary Proteins / Q000494:pharmacology*; D004656:Enalapril / Q000494:pharmacology*; D005921:Glomerulonephritis / Q000378:metabolism*; D007687:Kidney Tubules, Proximal / Q000187:drug effects* / Q000378:metabolism*; D008297:Male; D008845:Microinjections; D009994:Osmolar Concentration; D051381:Rats; D017207:Rats, Sprague-Dawley
D000418:Albumins; D004044:Dietary Proteins; D004656:Enalapril